Institutional Manager · CIK 0001715579
Medicxi Ventures Management (Jersey) Ltd
ST. HELIER, Y9 · File #028-19833
Latest AUM
$835.0M
Positions
5
Top-10 Concentration
100.0%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| REDUCE | AURA BIOSCIENCES INC | AURA | 0 | $0 | -$2.2M |
| REDUCE | CENTESSA PHARMACEUTICALS PLC | CNTA | 0 | $0 | +$15.2M |
| REDUCE | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 0 | $0 | +$19.1M |
| REDUCE | PHATHOM PHARMACEUTICALS INC | PHAT | 0 | $0 | +$36.0M |
| REDUCE | RAPT THERAPEUTICS INC | 75382E109 | 0 | $0 | +$22.6M |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 20255 pos · $835.0M
- 13F HOLDINGS REPORTQ/E Sep 20255 pos · $744.4M
- 13F HOLDINGS REPORTQ/E Jun 20255 pos · $427.3M
- 13F HOLDINGS REPORTQ/E Mar 20255 pos · $437.7M
- 13F HOLDINGS REPORTQ/E Dec 20245 pos · $529.0M
- 13F HOLDINGS REPORTQ/E Sep 20244 pos · $528.9M
- 13F HOLDINGS REPORTQ/E Jun 20244 pos · $335.3M
- 13F HOLDINGS REPORTQ/E Mar 20245 pos · $449.2M
- 13F HOLDINGS REPORTQ/E Dec 20236 pos · $313.2M
Top 5 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | CNTA | 19,963,157 | $499.3M | 59.80% |
| 2 | PHATHOM PHARMACEUTICALS INC | PHAT | 7,464,572 | $123.8M | 14.83% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 2,869,565 | $100.7M | 12.06% |
| 4 | RAPT THERAPEUTICS INC | 75382E109 | 2,794,000 | $94.6M | 11.33% |
| 5 | AURA BIOSCIENCES INC | AURA | 3,039,892 | $16.6M | 1.98% |